<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07455</article-id><article-id pub-id-type="doi">10.7554/eLife.07455</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Reduced matrix rigidity promotes neonatal cardiomyocyte dedifferentiation, proliferation and clonal expansion</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-31733"><name><surname>Yahalom-Ronen</surname><given-names>Yfat</given-names></name><aff><institution content-type="dept">Department of Biological Regulation</institution>, <institution>Weizmann Institute of Science</institution>, <addr-line><named-content content-type="city">Rehovot</named-content></addr-line>, <country>Israel</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-38907"><name><surname>Rajchman</surname><given-names>Dana</given-names></name><aff><institution content-type="dept">Department of Biological Regulation</institution>, <institution>Weizmann Institute of Science</institution>, <addr-line><named-content content-type="city">Rehovot</named-content></addr-line>, <country>Israel</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31734"><name><surname>Sarig</surname><given-names>Rachel</given-names></name><aff><institution content-type="dept">Department of Biological Regulation</institution>, <institution>Weizmann Institute of Science</institution>, <addr-line><named-content content-type="city">Rehovot</named-content></addr-line>, <country>Israel</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9318"><name><surname>Geiger</surname><given-names>Benjamin</given-names></name><aff><institution content-type="dept">Department of Molecular Cell Biology</institution>, <institution>Weizmann Institute of Science</institution>, <addr-line><named-content content-type="city">Rehovot</named-content></addr-line>, <country>Israel</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-27949"><name><surname>Tzahor</surname><given-names>Eldad</given-names></name><aff><institution content-type="dept">Department of Biological Regulation</institution>, <institution>Weizmann Institute of Science</institution>, <addr-line><named-content content-type="city">Rehovot</named-content></addr-line>, <country>Israel</country><email>eldad.tzahor@weizmann.ac.il</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1185"><name><surname>Srivastava</surname><given-names>Deepak</given-names></name><role>Reviewing editor</role><aff><institution>Gladstone Institute of Cardiovascular Disease</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>08</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e07455</elocation-id><supplementary-material><ext-link xlink:href="elife-07455-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>16</day><month>03</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Yahalom-Ronen et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Yahalom-Ronen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Cardiomyocyte (CM) maturation in mammals is accompanied by a sharp decline in their proliferative and regenerative potential shortly after birth. In this study, we explored the role of the mechanical properties of the underlying matrix in the regulation of CM maturation. We show that rat and mouse neonatal CMs cultured on rigid surfaces exhibited increased myofibrillar organization, spread morphology, and reduced cell cycle activity. In contrast, compliant elastic matrices induced features of CM dedifferentiation, including disorganized sarcomere network, rounding, and conspicuous cell-cycle re-entry. The rigid matrix facilitated nuclear division (karyokinesis) leading to binucleation, while compliant matrices promoted CM mitotic rounding and cell division (cytokinesis), associated with loss of differentiation markers. Moreover, the compliant matrix potentiated clonal expansion of CMs that involves multiple cell divisions. Thus, the compliant microenvironment facilitates CM dedifferentiation and proliferation via its effect on the organization of the myoskeleton. Our findings may be exploited to design new cardiac regenerative approaches.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The experiments were approved by the Animal Care and Use Committee of the Weizmann Institute of Science.</p></fn></fn-group></back></article>